Scientists launch Largest-Ever study of Ultra-Rare GSDs
NCT ID NCT06795152
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks 200 people with ultra-rare glycogen storage diseases (GSDs) like types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome, and Danon disease. Researchers will collect medical records and other data to see how these conditions progress over time. No treatments or drugs are being tested—the goal is simply to learn more about these rare diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DANON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University
RECRUITINGDurham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smarter glucose monitor stop dangerous lows? small study tests predictive alerts
- Heart condition costs under the microscope in massive hospital study
- Robotic leg device shows promise for helping muscle disease patients walk
- Robotic exoskeleton shows promise for muscle disease patients
- New scan techniques aim to solve rare heart disease mysteries
- New mRNA therapy aims to control blood sugar in rare genetic disease